William D Kerns

This inventor holds 5 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Synchroneuron, Inc.. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William D Kerns. Retrieved from https://idiyas.com/inventor/william-d-kerns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 43(Granted Patents)

Location History:

Harvard, MA (US) (2016)
Duxbury, MA (US) (2019)

Company Filing History:

5 out of 15

Synchroneuron, Inc.

patents

Years Active: 2016-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10512621 - Methods of treating posttraumatic stress disorder with acamprosate salts (2019-12-24),

2. 10166207 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2019-01-01),

3. 9427420 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-30),

4. 9421179 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-23),

5. 9421178 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-23),

Title: The Innovations of William D. Kerns

Introduction

William D. Kerns is a notable inventor based in Harvard, MA (US), recognized for his contributions to the field of medicine, particularly in the treatment of posttraumatic stress disorder (PTSD). With a total of five patents to his name, Kerns has made significant strides in developing innovative methods and formulations that aim to improve mental health outcomes.

Latest Patents

Kerns' latest patents focus on methods of treating PTSD using acamprosate salts. The embodiments disclosed in these patents relate to the use of acamprosate formulations, either alone or in combination with other medications, such as neuroleptic (antipsychotic) and antidepressant drugs. These formulations and methods are designed to provide effective treatment options for individuals suffering from PTSD, showcasing Kerns' commitment to advancing mental health therapies.

Career Highlights

Throughout his career, Kerns has worked with various organizations, including Synchroneuron, Inc. and Eisai R&D Management Co., Ltd. His experience in these companies has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research and development efforts.

Collaborations

Kerns has collaborated with notable coworkers such as Barry S. Fogel and Kei-Lai Fong. These partnerships have played a crucial role in enhancing the quality and impact of his work in the medical field.

Conclusion

William D. Kerns is a distinguished inventor whose work in developing methods for treating PTSD has the potential to transform mental health care. His innovative approaches and collaborations reflect his dedication to improving the lives of those affected by mental health disorders.

Profile summary based on public USPTO records.